Dr. William T. Tse
Claim this profileMetroHealth Medical Center
Expert in Cancer
Studies Lung Cancer
49 reported clinical trials
117 drugs studied
Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage I
2Lung Cancer
Stage II
Stage III
Stage I
Affiliated Hospitals
Clinical Trials William T. Tse is currently running
Lomustine + Standard Therapy
for Glioblastoma
This phase III trial compares the effect of adding lomustine to temozolomide and radiation therapy versus temozolomide and radiation therapy alone in shrinking or stabilizing newly diagnosed MGMT methylated glioblastoma. Chemotherapy drugs, such as lomustine and temozolomide, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Radiation therapy uses high energy photons to kill tumor cells and shrink tumors. Adding lomustine to usual treatment of temozolomide and radiation therapy may help shrink and stabilize glioblastoma.
Recruiting2 awards Phase 34 criteria
High-Dose vs Low-Dose Cisplatin with Radiation
for Head and Neck Cancer
This phase II/III trial compares the effect of the combination of high-dose cisplatin every three weeks and radiation therapy versus low-dose cisplatin weekly and radiation therapy for the treatment of patients with locoregionally advanced head and neck cancer. Chemotherapy drugs, such as cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. This study is being done to find out if low-dose cisplatin given weekly together with radiation therapy is the same or better than high-dose cisplatin given every 3 weeks together with radiation therapy in treating patients with head and neck cancer.
Recruiting1 award Phase 2 & 335 criteria
More about William T. Tse
Clinical Trial Related4 years of experience running clinical trials · Led 49 trials as a Principal Investigator · 22 Active Clinical TrialsTreatments William T. Tse has experience with
- Nivolumab
- Cisplatin
- Paclitaxel
- Ipilimumab
- Atezolizumab
- Pembrolizumab
Breakdown of trials William T. Tse has run
Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Squamous Cell Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does William T. Tse specialize in?
William T. Tse focuses on Cancer and Lung Cancer. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are Stage III.
Is William T. Tse currently recruiting for clinical trials?
Yes, William T. Tse is currently recruiting for 22 clinical trials in Cleveland Ohio. If you're interested in participating, you should apply.
Are there any treatments that William T. Tse has studied deeply?
Yes, William T. Tse has studied treatments such as Nivolumab, Cisplatin, Paclitaxel.
What is the best way to schedule an appointment with William T. Tse?
Apply for one of the trials that William T. Tse is conducting.
What is the office address of William T. Tse?
The office of William T. Tse is located at: MetroHealth Medical Center, Cleveland, Ohio 44109 United States. This is the address for their practice at the MetroHealth Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.